Isbn: 9789819773794 - angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers: a critical analysis of antihypertensive strategies: a machine-generated literature overview (10 risultati)

Perfeziona la tua ricerca

  • Libri (10)

  • Nuovo (10)

a

Fascia di prezzo personalizzata (EUR)

a

  • Lingua: Inglese

    Editore: Springer, 2024

    9819773792 / 9789819773794

    • Rilegato

    Da: Brook Bookstore On Demand, Napoli, NA, ItaliaBrook Bookstore On Demand

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 142,27

    EUR 11,00 spedizione 
    Spedito da Italia a U.S.A.

    Quantità: 10 disponibili

    Condizione: new.

  • Lingua: Inglese

    Editore: Springer Verlag, Singapore, Singapore, 2024

    9819773792 / 9789819773794

    • Rilegato

    Da: Grand Eagle Retail, Bensenville, IL, U.S.A.Grand Eagle Retail

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 162,10

     Spedizione gratuita 
    Spedito in U.S.A.

    Quantità: 1 disponibili

    Hardcover. Condizione: new. Hardcover. This book delves into the various aspects of the renin-angiotensin-aldosterone system (RAAS) and its role in cardiovascular disorders. It explores the use of anti-hypertensive agents, with a focus on (ACE) angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ARBs). The chapters cover topics such as the preferred use of ACE inhibitors over ARBs in high-risk patients, the impact of these agents on insulin resistance, their role in acute heart failure and peripheral artery disease, and their immunomodulatory activity in hypertensive patients. Additionally, the book examines the role of ACE inhibitors and ARBs in COVID-19 patients and provides insights into recent trends in managing hypertension through RAAS inhibition. It serves as a valuable resource for researchers, clinicians, and healthcare professionals involved in the field of cardiovascular medicine. The chapters cover topics such as the preferred use of ACE inhibitors over ARBs in high-risk patients, the impact of these agents on insulin resistance, their role in acute heart failure and peripheral artery disease, and their immunomodulatory activity in hypertensive patients. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

  • Lingua: Inglese

    Editore: Springer, 2024

    9819773792 / 9789819773794

    • Rilegato

    Da: Brook Bookstore, Milano, MI, ItaliaBrook Bookstore

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 137,54

    EUR 37,99 spedizione 
    Spedito da Italia a U.S.A.

    Quantità: 10 disponibili

    Condizione: new.

  • Condizione: Nuovo

    EUR 168,15

    EUR 17,49 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: 2 disponibili

    Hardcover. Condizione: Brand New. 616 pages. 9.26x6.11x9.49 inches. In Stock.

  • Condizione: Nuovo

    EUR 285,88

    EUR 17,49 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: 2 disponibili

    Hardcover. Condizione: Brand New. 616 pages. 9.26x6.11x9.49 inches. In Stock.

  • Condizione: Nuovo

    EUR 255,87

    EUR 38,84 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 1 disponibili

    Buch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book delves into the various aspects of the renin-angiotensin-aldosterone system (RAAS) and its role in cardiovascular disorders. It explores the use of anti-hypertensive agents, with a focus on (ACE) angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ARBs). The chapters cover topics such as the preferred use of ACE inhibitors over ARBs in high-risk patients, the impact of these agents on insulin resistance, their role in acute heart failure and peripheral artery disease, and their immunomodulatory activity in hypertensive patients. Additionally, the book examines the role of ACE inhibitors and ARBs in COVID-19 patients and provides insights into recent trends in managing hypertension through RAAS inhibition. It serves as a valuable resource for researchers, clinicians, and healthcare professionals involved in the field of cardiovascular medicine.

  • Lingua: Inglese

    Editore: Springer Verlag, Singapore, Singapore, 2024

    9819773792 / 9789819773794

    • Rilegato

    Da: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 271,26

    EUR 32,21 spedizione 
    Spedito da Australia a U.S.A.

    Quantità: 1 disponibili

    Hardcover. Condizione: new. Hardcover. This book delves into the various aspects of the renin-angiotensin-aldosterone system (RAAS) and its role in cardiovascular disorders. It explores the use of anti-hypertensive agents, with a focus on (ACE) angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ARBs). The chapters cover topics such as the preferred use of ACE inhibitors over ARBs in high-risk patients, the impact of these agents on insulin resistance, their role in acute heart failure and peripheral artery disease, and their immunomodulatory activity in hypertensive patients. Additionally, the book examines the role of ACE inhibitors and ARBs in COVID-19 patients and provides insights into recent trends in managing hypertension through RAAS inhibition. It serves as a valuable resource for researchers, clinicians, and healthcare professionals involved in the field of cardiovascular medicine. The chapters cover topics such as the preferred use of ACE inhibitors over ARBs in high-risk patients, the impact of these agents on insulin resistance, their role in acute heart failure and peripheral artery disease, and their immunomodulatory activity in hypertensive patients. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.

  • Lingua: Inglese

    Editore: Springer Verlag GmbH, 2024

    9819773792 / 9789819773794

    • Rilegato
    • Print on Demand

    Da: moluna, Greven, Germaniamoluna

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 153,73

    EUR 48,99 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: Più di 20 disponibili

    Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt.

  • Lingua: Inglese

    Editore: Springer, Springer Okt 2024, 2024

    9819773792 / 9789819773794

    • Rilegato
    • Print on Demand

    Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 181,89

    EUR 23,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 2 disponibili

    Buch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book delves into the various aspects of the renin-angiotensin-aldosterone system (RAAS) and its role in cardiovascular disorders. It explores the use of anti-hypertensive agents, with a focus on (ACE) angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ARBs). The chapters cover topics such as the preferred use of ACE inhibitors over ARBs in high-risk patients, the impact of these agents on insulin resistance, their role in acute heart failure and peripheral artery disease, and their immunomodulatory activity in hypertensive patients. Additionally, the book examines the role of ACE inhibitors and ARBs in COVID-19 patients and provides insights into recent trends in managing hypertension through RAAS inhibition. It serves as a valuable resource for researchers, clinicians, and healthcare professionals involved in the field of cardiovascular medicine. 616 pp. Englisch.

  • Lingua: Inglese

    Editore: Springer, Springer Okt 2024, 2024

    9819773792 / 9789819773794

    • Rilegato
    • Print on Demand

    Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 181,89

    EUR 60,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 1 disponibili

    Buch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book delves into the various aspects of the renin-angiotensin-aldosterone system (RAAS) and its role in cardiovascular disorders. It explores the use of anti-hypertensive agents, with a focus on (ACE) angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ARBs). The chapters cover topics such as the preferred use of ACE inhibitors over ARBs in high-risk patients, the impact of these agents on insulin resistance, their role in acute heart failure and peripheral artery disease, and their immunomodulatory activity in hypertensive patients. Additionally, the book examines the role of ACE inhibitors and ARBs in COVID-19 patients and provides insights into recent trends in managing hypertension through RAAS inhibition.It serves as a valuable resource for researchers, clinicians, and healthcare professionals involved in the field of cardiovascular medicine.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 616 pp. Englisch.